Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
2022 · Neurology and Therapy · 40 citations
https://doi.org/10.1007/s40120-022-00364-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
141
Citations
6
h-index
3
i10-index
Elena Barbuti is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 6, co-authored 17 publications.
ORCID: 0000-0002-0450-7699https://doi.org/10.1007/s40120-022-00364-6
https://doi.org/10.1016/j.neurot.2025.e00537
Click to start Chat